Updated on 21 June 2013
Dr P M Murali, president, Association of Biotechnology Led Enterprises (ABLE) and managing director and CEO, Evolva Biotech, India
Association of Biotechnology Led Enterprises (ABLE) is a not-for-profit pan-India forum that was launched in April 2003. It has over 400 members from all across the Indian biotechnology industry, representing all domains like agribiotech, bio-pharma, industrial biotech, bioinformatics, investment banks and venture capital firms, leading research and academic institutes and law firms and equipment suppliers.
Dr P M Murali, president, ABLE and managing director and CEO, Evolva Biotech, shares his views on how the associations is helping Indian life science firms.
What is the total number of members of ABLE? What is the eligibility to become a member?
Dr Murali: ABLE has nearly 400 members currently as on April 19, 2013, belonging to different biotechnology segments. However, the total number of active member is just around the 200 mark.
ABLE offers four categories of membership, including membership by invitation, ordinary membership, associate membership and foreign membership. The Membership by Invitation
category is by invitation only and is reserved for companies or individuals who wish to contribute to ABLE. We currently have three different categories under this, including Patron, Sustaining and Affiliate. In Ordinary Membership, biotech companies that have a registered office in India are eligible to become members. Again under this category we have different slabs, based on company turn over and year of business inception. In Associate Membership, individuals and institutions that have an interest in the Indian Biotechnology industry are eligible, including Indian Government and private bodies, research and academic institutions, ancillary and supporting entities, individual members (indian), NGOs, and supporting companies (banks). In Foreign Membership, individual and companies/corporate can be our member provided they are registered company in their respective countries. And same applies to the individual foreign members as per his or her nationality.
Could you tell us about the major focus areas of the association?
Dr Murali: Our primary focus and objective at ABLE is to catalyses a symbiotic interface between the industry, the government, academic and research institutes both domestic and international to accelerate the pace of growth of the biotechnology sector in India, through partnering with the Government in their biotechnology initiatives to deliver optimal policies and create a positive regulatory environment, encouraging entrepreneurship and investment in the sector, providing a platform for domestic and overseas companies to explore collaboration and partnerships, forging stronger links between academia and industry and showcasing strengths of the Indian biotech sector. Our major focus areas are agriculture, advocacy and regulatory, HR and educational, IP and legal, regenerative medicine, omics, bio-energy, and VC and finance.